How do I handle a nonconforming peptide batch?
What steps should a laboratory take to document a nonconforming peptide batch, assess its impact, contact the supplier, and determine whether further testing is warranted?
通用回答
A nonconforming peptide batch is any lot that fails to meet its specification—purity by HPLC, identity by mass spectrometry, appearance, sterility, endotoxin, or water content. Handling it well protects your data, your budget, and your supplier relationship. The workflow below is what experienced lab and sourcing teams typically follow.
1. Stop and quarantine. Immediately place the lot in a segregated, labeled area (physical or in your inventory system) marked "QUARANTINE – DO NOT USE." Record the lot number, vial count, receipt date, and the exact test that failed. Do not discard the material; you may need it for retesting or a supplier claim.
2. Document the nonconformance. Open a formal nonconformance report (NCR) that captures: product name and lot, supplier and PO number, date received, storage conditions since receipt, the specification limit, the observed result, the analytical method and instrument used, and the analyst's name and date. Attach the raw data—chromatograms, spectra, and photos of the vial and label. Keep a chronological log of every action and communication.
3. Assess impact. Ask three questions. First, was the material used in any experiment? If so, identify which samples, animals, or assays are affected and flag those results as suspect. Second, is the deviation a true product failure or a testing artifact—for example, degraded peptide from improper storage, a mis-injection, or a calibration issue? Third, what is the risk level? A cosmetic issue (clumped lyophilized cake) is low risk; a purity shortfall or failed identity test is high risk and may invalidate prior work. Decide whether affected experiments must be repeated.
4. Retest before blaming the supplier. Where sample remains, confirm the failure with a second method or a fresh vial from the same lot. Check that your storage and handling matched the supplier's instructions. Many apparent failures trace to reconstitution, freeze-thaw cycles, or light exposure rather than manufacturing.
5. Contact the supplier promptly. Send a concise, factual message: lot number, PO, the failing specification, your result with method details, and photos. Ask for their certificate of analysis for that lot, their retained-sample data, and their proposed remedy (replacement, credit, or refund). Keep the tone collaborative—suppliers respond faster to clear data than to complaints. If you are sourcing from overseas factories or trading partners and need help comparing suppliers, vetting documentation, or resolving a shipment dispute, our team supports helping U.S. research-peptide customers find, compare, and evaluate Chinese research-peptide raw-material factories and Chinese peptide lyophilized-powder vial factories, along with business consulting and customs-clearance consulting for peptide international trade.
6. Decide on further testing. Escalate to additional testing when: the first result is borderline or ambiguous; the deviation affects a regulated or high-value study; the supplier disputes your finding; or the lot will be used in vivo. Useful follow-ups include repeat HPLC at higher resolution, LC-MS for identity, amino-acid analysis, endotoxin and sterility testing, and water-content assay. For high-stakes lots, consider third-party testing at an independent lab—this carries more weight in a supplier claim.
7. Close the loop. Document the root cause, the corrective action (replacement lot, new supplier, revised receiving SOP), and the effectiveness check. Update your approved-supplier list and receiving-inspection plan so the same failure is caught earlier next time. If the batch came through international shipping, review cold-chain and packaging records with your logistics provider; our double-clearance, tax-included cross-border logistics service and China peptide international logistics providers evaluation support can help you trace where a temperature or handling excursion occurred.
In short: quarantine, document, assess, retest, communicate, escalate testing only when justified, and close with a corrective action. This sequence keeps your science defensible and gives you the evidence needed for a fair resolution with any supplier.
这些解答为一般行业信息,不构成监管、医疗或法律意见。具体产品的监管状态、进口规则与临床适用性须按产品、司法辖区与预期用途核实。